Glyx Therapeutics
Glyx Therapeutics is at the forefront of the development of lipid-linked anionic oligosaccharides (LAOs) for the treatment of tauopathies, including Alzheimer’s disease. This innovative approach offers a promising alternative to…
Glyx Therapeutics is at the forefront of the development of lipid-linked anionic oligosaccharides (LAOs) for the treatment of tauopathies, including Alzheimer’s disease. This innovative approach offers a promising alternative to…

GnRHope Therapeutics aims to launch to market a pulsatile gonadotropin-releasing hormone (GnRH) therapy for patients suffering from cognition deficits (due to chromosomal abnormalities (Prader-Willi, Down Syndrom), or age-related cognitive decline),…

InVenis Biotherapies is a biotech compagny developping innovative regenerative therapies based on blood platelet. Thanks to the high therapeutic potential of our product, we target the most severe diseases involving…

PWI, an innovative project, is developing a treatment based on GnRH (gonadotropin-releasing hormone) antagonists, repositioned in a clinical trial to treat the deleterious effects on reproduction and metabolism induced by…